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  Of 57 patients with renal cell carcinoma admitted to our hospital or a collaborating hospital
from January 1966 through December 1980， 16 patients were diagnosed to have stage IV cancey．
The therapeutic results of these 16 patients are presented in this paper．
  The patients were 4 females and 12 males， and ranged in age from 48 to 71 years， with an average
of 59．9 years． Metastatic・lesions were seen in the lungs in 6 patients， in the bones in 3 patients， in
the liver in 3 patients， in both the lungs and bones in 2 patients， in the distant iymph nodes in 2 patients，
and ill the skin in l patient． Palliative nephrecto皿y was performed on l O patients． Their survival
rates were 50．0％at 6 months，40。0％atユyear． and 28．6％at 2 years． Four out of 6 patients given
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Table． 1． Sympotoms and laberatory findings
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率についてみるとgrade 1は66．7％， grade 2は50．7
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Fig． 1． Survival rate of advanced renal cell
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